发明名称 |
METHODS OF MONITORING ADHERENCE TO HALOPERIDOL THERAPY |
摘要 |
The present disclosure provides methods for monitoring subject (e.g., patient) adherence to Haldol therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia. |
申请公布号 |
US2017029866(A1) |
申请公布日期 |
2017.02.02 |
申请号 |
US201615223579 |
申请日期 |
2016.07.29 |
申请人 |
Ameritox, Ltd |
发明人 |
Strickland Erin;Cummings Oneka;McIntire Gregory L. |
分类号 |
C12Q1/40 |
主分类号 |
C12Q1/40 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for monitoring haloperidol (Haldol) therapy in a subject comprising:
identifying a subject who has been prescribed Haldol therapy; obtaining a fluid sample from the subject; hydrolyzing the sample; analyzing the fluid sample for the presence of haloperidol; and identifying the subject as adherent to the prescribed Haldol therapy if the hydrolysed fluid sample contains Haldol above a threshold level but non-adherent if the hydrolysed fluid sample contains no Haldol or an amount of Haldol below a threshold level. |
地址 |
Baltimore MD US |